Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study.

ABSTRACT:

Background

Current guidelines recommend extending the use of dual antiplatelet therapy (DAPT) beyond 1 year in patients with an acute coronary syndrome (ACS) and a high risk of ischaemia and low risk of bleeding. No data exist about the implementation of this strategy in older adults from routine clinical practice.

Methods

We conducted a Spanish multicentre, retrospective, observational registry-based study that included patients with ACS but no thrombotic or bleeding events during the first year of DAPT after discharge and no indication for oral anticoagulants. High bleeding risk was defined according to the Academic Research Consortium definition. We assessed the proportion of cases of extended DAPT among patients 65 ≥ years that went beyond 1 year after hospitalisation fo

SUBMITTER: Ariza-Sole A 

PROVIDER: S-EPMC10031931 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature